Novo Nordisk A S SEC filings NVO
Novo Nordisk A S has 1,001 filings in SEC EDGAR's recent list, going back to Apr 1, 2016. Its latest annual report, Form 20-F, was filed on Feb 4, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 4, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| F-6 | Form f-6 | Aug 31, 2023 | — |
| S-8 | Employee stock plan registration | Mar 24, 2022 | — |
| S-8 | Employee stock plan registration | Feb 8, 2018 | — |
| S-8 | Employee stock plan registration | Oct 31, 2017 | — |
| F-6 POS | Filing | Mar 2, 2017 | — |
Showing 5 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NVO (NYSE), NONOF (OTC)
- Fiscal year ends
- December 31
- Headquarters
- Bagsvaerd Denmark, Denmark
- SEC filer status
- Large accelerated filer
- SEC CIK
- 353278
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Pfizer Inc PFE
Source: SEC EDGAR filings. This is company-reported data, not investment advice.